Log in

China SXT Pharmaceuticals Stock Price, News & Analysis (NASDAQ:SXTC)

$1.19
+0.21 (+21.43 %)
(As of 10/14/2019 07:57 AM ET)
Today's Range
$1.00
Now: $1.19
$1.24
50-Day Range
$0.95
MA: $1.93
$2.71
52-Week Range
$0.91
Now: $1.19
$23.35
Volume420,310 shs
Average Volume111,012 shs
Market Capitalization$31.78 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives. China SXT Pharmaceuticals, Inc. was founded in 2005 and is based in Taizhou, China.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SXTC
CUSIPN/A
CIKN/A
Phone86-523-8629-8290

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.01 million
Cash Flow$0.09 per share
Book Value$0.49 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$31.78 million
Next Earnings Date11/18/2019 (Estimated)
OptionableNot Optionable

Receive SXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter.


China SXT Pharmaceuticals (NASDAQ:SXTC) Frequently Asked Questions

What is China SXT Pharmaceuticals' stock symbol?

China SXT Pharmaceuticals trades on the NASDAQ under the ticker symbol "SXTC."

When is China SXT Pharmaceuticals' next earnings date?

China SXT Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, November 18th 2019. View Earnings Estimates for China SXT Pharmaceuticals.

Has China SXT Pharmaceuticals been receiving favorable news coverage?

News headlines about SXTC stock have trended negative this week, according to InfoTrie. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. China SXT Pharmaceuticals earned a news sentiment score of -2.6 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for China SXT Pharmaceuticals.

Are investors shorting China SXT Pharmaceuticals?

China SXT Pharmaceuticals saw a decrease in short interest in September. As of September 30th, there was short interest totalling 21,400 shares, a decrease of 74.9% from the August 30th total of 85,400 shares. Based on an average daily volume of 40,400 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.2% of the shares of the stock are sold short. View China SXT Pharmaceuticals' Current Options Chain.

Who are some of China SXT Pharmaceuticals' key competitors?

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include HEXO (HEXO), Iconix Brand Group (ICON), Cesca Therapeutics (KOOL), SCYNEXIS (SCYX), Zynerba Pharmaceuticals (ZYNE), NIO (NIO), Golden Minerals (AUMN), Arena Pharmaceuticals (ARNA), Applied DNA Sciences (APDN) and Amyris (AMRS).

Who are China SXT Pharmaceuticals' key executives?

China SXT Pharmaceuticals' management team includes the folowing people:
  • Mr. Feng Zhou, Chairman & CEO (Age 27)
  • Mr. Yao Shi, Chief Financial Officer (Age 38)
  • Dr. Jingzhen Deng, Chief Scientific Officer & COO (Age 59)
  • Mr. Jun Zheng, Exec. Director (Age 40)

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is China SXT Pharmaceuticals' stock price today?

One share of SXTC stock can currently be purchased for approximately $1.19.

How big of a company is China SXT Pharmaceuticals?

China SXT Pharmaceuticals has a market capitalization of $31.78 million and generates $7.01 million in revenue each year. View Additional Information About China SXT Pharmaceuticals.

What is China SXT Pharmaceuticals' official website?

The official website for China SXT Pharmaceuticals is http://www.sxtchina.com/.

How can I contact China SXT Pharmaceuticals?

China SXT Pharmaceuticals' mailing address is 178 TAIDONG ROAD NORTH, TAIZHOU F4, 225300. The company can be reached via phone at 86-523-8629-8290 or via email at [email protected]


MarketBeat Community Rating for China SXT Pharmaceuticals (NASDAQ SXTC)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  44 (Vote Outperform)
Underperform Votes:  73 (Vote Underperform)
Total Votes:  117
MarketBeat's community ratings are surveys of what our community members think about China SXT Pharmaceuticals and other stocks. Vote "Outperform" if you believe SXTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SXTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Featured Article: Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel